1. Home
  2. ENVX vs ARQT Comparison

ENVX vs ARQT Comparison

Compare ENVX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVX
  • ARQT
  • Stock Information
  • Founded
  • ENVX 2006
  • ARQT 2016
  • Country
  • ENVX United States
  • ARQT United States
  • Employees
  • ENVX N/A
  • ARQT N/A
  • Industry
  • ENVX Industrial Machinery/Components
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENVX Miscellaneous
  • ARQT Health Care
  • Exchange
  • ENVX Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • ENVX 1.5B
  • ARQT 1.7B
  • IPO Year
  • ENVX N/A
  • ARQT 2020
  • Fundamental
  • Price
  • ENVX $8.23
  • ARQT $13.82
  • Analyst Decision
  • ENVX Strong Buy
  • ARQT Strong Buy
  • Analyst Count
  • ENVX 11
  • ARQT 6
  • Target Price
  • ENVX $18.27
  • ARQT $18.80
  • AVG Volume (30 Days)
  • ENVX 3.6M
  • ARQT 1.9M
  • Earning Date
  • ENVX 07-30-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • ENVX N/A
  • ARQT N/A
  • EPS Growth
  • ENVX N/A
  • ARQT N/A
  • EPS
  • ENVX N/A
  • ARQT N/A
  • Revenue
  • ENVX $22,900,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • ENVX $55.18
  • ARQT $61.15
  • Revenue Next Year
  • ENVX $253.52
  • ARQT $37.98
  • P/E Ratio
  • ENVX N/A
  • ARQT N/A
  • Revenue Growth
  • ENVX 77.59
  • ARQT 100.03
  • 52 Week Low
  • ENVX $5.27
  • ARQT $7.86
  • 52 Week High
  • ENVX $18.68
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • ENVX 52.26
  • ARQT 50.73
  • Support Level
  • ENVX $8.03
  • ARQT $12.97
  • Resistance Level
  • ENVX $9.03
  • ARQT $13.84
  • Average True Range (ATR)
  • ENVX 0.50
  • ARQT 0.61
  • MACD
  • ENVX -0.04
  • ARQT 0.02
  • Stochastic Oscillator
  • ENVX 50.60
  • ARQT 51.64

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: